Hawkins (NASDAQ:HWKN) Announces Quarterly Earnings Results

Hawkins (NASDAQ:HWKN) posted its quarterly earnings data on Wednesday. The specialty chemicals company reported $0.74 earnings per share for the quarter, missing the consensus estimate of $0.76 by ($0.02), FiscalAI reports. Hawkins had a return on equity of 16.85% and a net margin of 7.75%.The business had revenue of $265.91 million during the quarter, compared to analysts’ expectations of $255.28 million.

Hawkins Stock Performance

Shares of HWKN traded down $6.76 during mid-day trading on Wednesday, hitting $161.83. The stock had a trading volume of 210,138 shares, compared to its average volume of 169,644. The firm has a market cap of $3.38 billion, a P/E ratio of 40.97, a PEG ratio of 3.23 and a beta of 0.81. The business has a fifty day moving average price of $153.61 and a 200-day moving average price of $146.15. The company has a debt-to-equity ratio of 0.49, a current ratio of 2.35 and a quick ratio of 1.46. Hawkins has a 52 week low of $115.35 and a 52 week high of $186.15.

Institutional Trading of Hawkins

Hedge funds have recently made changes to their positions in the company. Kestra Advisory Services LLC bought a new stake in shares of Hawkins in the fourth quarter valued at $29,000. Simplex Trading LLC raised its stake in shares of Hawkins by 246.0% in the fourth quarter. Simplex Trading LLC now owns 346 shares of the specialty chemicals company’s stock valued at $49,000 after buying an additional 246 shares during the period. Advisory Services Network LLC bought a new stake in shares of Hawkins during the 3rd quarter valued at $79,000. iSAM Funds UK Ltd bought a new stake in shares of Hawkins during the 3rd quarter valued at $102,000. Finally, Evergreen Capital Management LLC bought a new stake in shares of Hawkins during the 2nd quarter valued at $208,000. 69.71% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several research analysts have weighed in on the company. BWS Financial reissued a “buy” rating and issued a $200.00 price objective on shares of Hawkins in a research report on Monday, March 23rd. Weiss Ratings reissued a “hold (c+)” rating on shares of Hawkins in a research report on Friday, April 10th. One equities research analyst has rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $200.00.

About Hawkins

Hawkins, Inc (NASDAQ: HWKN) is a specialty chemical company that produces and distributes water-treatment and industrial chemicals across North America. Founded in 1938 and headquartered in Roseville, Minnesota, the company has built a network of manufacturing facilities and distribution centers that serve municipal, industrial and commercial customers. As a publicly traded entity, Hawkins leverages its long-standing presence in the chemical distribution industry to provide tailored solutions for complex water-treatment challenges and specialty chemical needs.

Hawkins’ product portfolio encompasses a wide range of chemicals, including sodium hypochlorite, sodium hydroxide, hydrogen peroxide, chlorine, acids and specialty blends.